Diabetic nephropathy induced by methylglyoxal: gallic acid regulates kidney microRNAs and glyoxalase1–Nrf2 in male mice

References

• Ahangarpour, A., et al., 2019. Hyperglycemia-induced oxidative stress in isolated proximal tubules of mouse: the in vitro effects of myricitrin and its solid lipid nanoparticle. Archives of physiology and biochemistry, 1–7. doi:10.1080/13813455.2019.1647250
   PubMed Web of Science ®Google Scholar
• Arai, M., et al., 2014. Measurement of glyoxalase activities. Biochemical society transactions, 42 (2), 491–494.
   PubMedGoogle Scholar
• Beisswenger, P.J., et al., 2013. Early progression of diabetic nephropathy correlates with methylglyoxal-derived advanced glycation end products. Diabetes care, 36 (10), 3234–3239.
   PubMed Web of Science ®Google Scholar
• Cha, S.-H., et al., 2018. Diphlorethohydroxycarmalol attenuates methylglyoxal-induced oxidative stress and advanced glycation end product formation in human kidney cells. Oxidative medicine and cellular longevity, 2018, 3654095.
   PubMed Web of Science ®Google Scholar
• Chen, Y.-J., et al., 2019. Hesperetin ameliorates diabetic nephropathy in rats by activating Nrf2/ARE/glyoxalase 1 pathway. Biomedicine & pharmacotherapy = biomedecine & pharmacotherapie, 111, 1166–1175.
   PubMed Web of Science ®Google Scholar
• Chiu, C.-C., et al., 2019. Upregulated expression of microRNA-204-5p leads to the death of dopaminergic cells by targeting DYRK1A-mediated apoptotic signaling cascade. Frontiers in cellular neuroscience, 13, 399.
   PubMed Web of Science ®Google Scholar
• Cullinan, S.B., and Diehl, J.A., 2004. PERK-dependent activation of Nrf2 contributes to redox homeostasis and cell survival following endoplasmic reticulum stress. Journal of biological chemistry, 279 (19), 20108–20117.
   PubMed Web of Science ®Google Scholar
• Cullinan, S.B., et al., 2003. Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival. Molecular and cellular biology, 23 (20), 7198–7209.
   PubMed Web of Science ®Google Scholar
• Do, M.H., et al., 2019. Therapeutic potential of Lespedeza bicolor to prevent methylglyoxal-induced glucotoxicity in familiar diabetic nephropathy. Journal of clinical medicine, 8 (8), 1138.
   PubMed Web of Science ®Google Scholar
• Do, M.H., et al., 2020. Syzygium aromaticum reduces diabetes-induced glucotoxicity via the NRF2/Glo1 pathway. Planta medica, 86 (12), 876–883.
   PubMed Web of Science ®Google Scholar
• Dornadula, S., et al., 2015. Pathophysiological insights of methylglyoxal induced type-2 diabetes. Chemical research in toxicology, 28 (9), 1666–1674.
   PubMed Web of Science ®Google Scholar
• Ebadi, Z., et al., 2019. Captopril and spironolactone can attenuate diabetic nephropathy in wistar rats by targeting microRNA-192 and microRNA-29a/b/c. DNA and cell biology, 38 (10), 1134–1142.
   PubMed Web of Science ®Google Scholar
• Fan, Y., et al., 2017. The role of endoplasmic reticulum stress in diabetic nephropathy. Current diabetes reports, 17 (3), 17.
   PubMed Web of Science ®Google Scholar
• Garud, M.S., and Kulkarni, Y.A., 2018. Gallic acid attenuates type I diabetic nephropathy in rats. Chemico-biological interactions, 282, 69–76.
   PubMed Web of Science ®Google Scholar
• Giacco, F., et al., 2014. Knockdown of glyoxalase 1 mimics diabetic nephropathy in nondiabetic mice. Diabetes, 63 (1), 291–299.
   PubMed Web of Science ®Google Scholar
• Hetz, C., and Papa, F.R., 2018. The unfolded protein response and cell fate control. Molecular cell, 69 (2), 169–181.
   PubMed Web of Science ®Google Scholar
• Hirakawa, Y., and Inagi, R., 2017. Glycative stress and its defense machinery glyoxalase 1 in renal pathogenesis. International journal of molecular sciences, 18 (1), 174.
   PubMed Web of Science ®Google Scholar
• Hsu, W.-H., et al., 2013. A novel natural Nrf2 activator with PPARγ-agonist (monascin) attenuates the toxicity of methylglyoxal and hyperglycemia. Toxicology and applied pharmacology, 272 (3), 842–851.
   PubMed Web of Science ®Google Scholar
• Jeong, S.-R., et al., 2020. Methylglyoxal-derived advanced glycation end products induce matrix metalloproteinases through activation of ERK/JNK/NF-κB pathway in kidney proximal epithelial cells. Food science and biotechnology, 29 (5), 675–682.
   PubMed Web of Science ®Google Scholar
• Kassan, M., et al., 2017. MicroRNA-204 promotes vascular endoplasmic reticulum stress and endothelial dysfunction by targeting Sirtuin1. Scientific reports, 7 (1), 1–11.
   PubMedGoogle Scholar
• Lange, T., et al., 2017. Identification of miR-16 as an endogenous reference gene for the normalization of urinary exosomal miRNA expression data from CKD patients. PLoS One, 12 (8), e0183435.
   PubMed Web of Science ®Google Scholar
• Lee, B.-H., et al., 2012. Ankaflavin: a natural novel PPARγ agonist upregulates Nrf2 to attenuate methylglyoxal-induced diabetes in vivo. Free radical biology and medicine, 53 (11), 2008–2016.
   PubMed Web of Science ®Google Scholar
• Liu, Y., et al., 2020. MBTPS2 exacerbates albuminuria in streptozotocin-induced type I diabetic nephropathy by promoting endoplasmic reticulum stress-mediated renal damage. Archives of physiology and biochemistry, 1–8. doi:10.1080/13813455.2020.1749084
   PubMed Web of Science ®Google Scholar
• Mao, Q., et al., 2019. Astragaloside IV inhibits excessive mesangial cell proliferation and renal fibrosis caused by diabetic nephropathy via modulation of the TGF-β1/Smad/miR-192 signaling pathway. Experimental and therapeutic medicine, 18 (4), 3053–3061.
   PubMed Web of Science ®Google Scholar
• Mard, S. A., et al., 2015. The anti-inflammatory and anti-apoptotic effects of gallic acid against mucosal inflammation-and erosions-induced by gastric ischemia-reperfusion in rats. Veterinary Research Forum. Faculty of Veterinary Medicine, Urmia University, Urmia, Iran, 305.
   Google Scholar
• Munusamy, S., et al., 2020. Low-dose metformin treatment ameliorates renal dysfunction and fibrosis in a mouse model of diabetic nephropathy. The FASEB journal, 34 (S1), 1–1.
   Google Scholar
• Parwani, K., and Mandal, P., 2020. Role of advanced glycation end products and insulin resistance in diabetic nephropathy. Archives of physiology and biochemistry, 1–13.
   PubMed Web of Science ®Google Scholar
• Punithavathi, V.R., et al., 2011. Antihyperglycaemic, antilipid peroxidative and antioxidant effects of gallic acid on streptozotocin induced diabetic Wistar rats. European journal of pharmacology, 650 (1), 465–471.
   PubMed Web of Science ®Google Scholar
• Qi, S.S., et al., 2020. Protective effects of chromium picolinate against diabetic-induced renal dysfunction and renal fibrosis in streptozotocin-induced diabetic rats. Biomolecules, 10 (3), 398.
   PubMed Web of Science ®Google Scholar
• Rena, G., et al., 2017. The mechanisms of action of metformin. Diabetologia, 60 (9), 1577–1585.
   Google Scholar
• Rodrigues, L., et al., 2014. Advanced glycation end products and diabetic nephropathy: a comparative study using diabetic and normal rats with methylglyoxal-induced glycation. Journal of physiology and biochemistry, 70 (1), 173–184.
   PubMed Web of Science ®Google Scholar
• Ruiz-Ortega, M., et al., 2020. Special Issue “Diabetic Nephropathy: Diagnosis, Prevention and Treatment”. Switzerland: Multidisciplinary Digital Publishing Institute.
   Google Scholar
• Shi, L., et al., 2014. MiR-204 inhibits human NSCLC metastasis through suppression of NUAK1. British journal of cancer, 111 (12), 2316–2327.
   PubMed Web of Science ®Google Scholar
• Topsakal, S., et al., 2017. The ameliorative effect of gallic acid on pancreas lesions induced by 2.45 GHz electromagnetic radiation (Wi-Fi) in young rats. Journal of radiation research and applied sciences, 10 (3), 233–240.
   Web of Science ®Google Scholar
• Ulubay, M., et al., 2020. The protective effect of curcumin on the diabetic rat kidney: a stereological, electron microscopic and immunohistochemical study. Acta histochemica, 122 (2), 151486.
   PubMed Web of Science ®Google Scholar
• Umadevi, S., Gopi, V., and Elangovan, V., 2014. Regulatory mechanism of gallic acid against advanced glycation end products induced cardiac remodeling in experimental rats. Chemico-biological interactions, 208, 28–36.
   PubMed Web of Science ®Google Scholar
• Wang, B., et al., 2020. Exogenous miR-29a attenuates muscle atrophy and kidney fibrosis in unilateral ureteral obstruction mice. Human gene therapy, 31 (5–6), 367–375.
   PubMed Web of Science ®Google Scholar
• Xu, G., et al., 2016. miR-204 targets PERK and regulates UPR signaling and β-cell apoptosis. Molecular endocrinology (Baltimore, MD), 30 (8), 917–924.
   PubMedGoogle Scholar
• Zheng, H.X., et al., 2020. Cyanidin-3-glucoside from black rice ameliorates diabetic nephropathy via reducing blood glucose, suppressing oxidative stress and inflammation, and regulating transforming growth factor β1/Smad expression. Journal of agricultural and food chemistry, 68 (15), 4399–4410.
   PubMed Web of Science ®Google Scholar
• Zhu, D., et al., 2014. (+)-Catechin ameliorates diabetic nephropathy by trapping methylglyoxal in type 2 diabetic mice. Molecular nutrition & food research, 58 (12), 2249–2260.
   PubMed Web of Science ®Google Scholar
• Zou, X.-Z., et al., 2017. MicroRNAs-mediated epithelial-mesenchymal transition in fibrotic diseases. European journal of pharmacology, 796, 190–206.
   PubMed Web of Science ®Google Scholar